Changes in Vectra scores provide quantitative insight to help assess your patients’ responses to therapy.
Vectra has assessed rheumatoid arthritis disease activity in response to many currently available therapeutic options, including:
- Methotrexate ± corticosteroids1,2,3
- Biologic therapy (abatacept, adalimumab, etanercept, golimumab, infliximab and tocilizumab*4-8)
Vectra algorithm scores differed significantly between EULAR response categories in anti-TNF-treated patients.5
The value of obtaining a baseline Vectra score